National Center of Neurology and Psychiatry

InstitutionResearch output, impact & collaborations

National Center of Neurology and Psychiatry is a research organisation in Tokyo, JP. OpenAlex records 13,863 works and 1,477,917 citations for it. 1,913 researchers list it as their most recent affiliation.

13,863

Works

1,477,917

Citations

1,913

Researchers

76.8

Avg h-index

IDs:ROR OpenAlex

How has National Center of Neurology and Psychiatry's publication output changed over time?

ScholarIQpublication output · 2004–2022

Output grew0% over the shown period — from 1 works in 2004 to 1 in 2022.

2004200720092010201120132014201720192022

Who are the most-cited researchers behind National Center of Neurology and Psychiatry?

ScholarIQtop researchers by citations

Masaki Takao · Orthopaedic implants and arthroplasty

379 works5,579 citations

What are the most-cited papers on National Center of Neurology and Psychiatry?

ScholarIQmost cited works

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Reisa A. Sperling, Paul Aisen, Laurel Beckett, David A. Bennett, Suzanne Craft, Anne M. Fagan, Takeshi Iwatsubo, Clifford R. Jack, Jeffrey Kaye, Thomas J. Montine, Denise C. Park, Eric M. Reiman, Christopher C. Rowe, Eric Siemers, Yaakov Stern, Kristine Yaffe, María C. Carrillo, Bill Thies, Marcelle Morrison‐Bogorad, Molly V. Wagster, Creighton H. Phelps

Alzheimer s & Dementia. 20117,190 CitationsOPEN ACCESS

Lecanemab in Early Alzheimer’s Disease

Christopher H. van Dyck, Chad J. Swanson, Paul Aisen, Randall J. Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno Vellas, David Watson, Shobha Dhadda, Michael C. Irizarry, Lynn D. Kramer, Takeshi Iwatsubo

New England Journal of Medicine. 20225,416 CitationsOPEN ACCESS

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

E. Sidransky, Mike A. Nalls, Jan Aasly, J. Aharon‐Peretz, Grazia Annesi, Egberto Reis Barbosa, Anat Bar‐Shira, Daniela Berg, José Brás, Alexis Brice, Chien‐Ming Chen, Lorraine N. Clark, Christel Condroyer, Elvira Valeria De Marco, Alexandra Dürr, Michael J. Eblan, S Fahn, Matthew J. Farrer, Hon‐Chung Fung, Ziv Gan‐Or, Thomas Gasser, Ruth Gershoni‐Baruch, Nir Giladi, Alida Griffith, Tanya Gurevich, Cristina Januário, Peter Kropp, Anthony E. Lang, Guey‐Jen Lee‐Chen, Suzanne Lesage, K. Marder, Ignácio F. Mata, Anat Mirelman, Jun Mitsui, Ikuko Mizuta, Giuseppe Nicoletti, Catarina R. Oliveira, Ruth Ottman, Avi Orr‐Urtreger, Lygia V. Pereira, Aldo Quattrone, Ekaterina Rogaeva, A. Rolfs, Hanna Rosenbaum, Roberto Rozenberg, Ali Samii, T. Samaddar, Claudia Schulte, Manu Sharma, Andrew Singleton, Mariana Spitz, Eng‐King Tan, N. Tayebi, Tatsushi Toda, A. R. Troiano, Shoji Tsuji, Matthias Wittstock, Tyra G. Wolfsberg, Yih‐Ru Wu, Cyrus P. Zabetian, Yirui Zhao, Shira G. Ziegler

New England Journal of Medicine. 20092,142 CitationsOPEN ACCESS

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs

New England Journal of Medicine. 20141,654 CitationsOPEN ACCESS

Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1

Masato Iwabu, Toshimasa Yamauchi, Miki Okada‐Iwabu, Koji Sato, Tatsuro Nakagawa, Masaaki Funata, Mamiko Yamaguchi, Shigeyuki Namiki, Ryo Nakayama, Mitsuhisa Tabata, Hitomi Ogata, Naoto Kubota, Iseki Takamoto, Yukiko Hayashi, Naoko Yamauchi, Hironori Waki, Masashi Fukayama, Ichizo Nishino, Kumpei Tokuyama, Kohjiro Ueki, Yuichi Oike, Satoshi Ishii, Kenzo Hirose, Takao Shimizu, Kazushige Touhara, Takashi Kadowaki

Nature. 2010970 Citations